Navigation Links
MammaPrint(R) Breast Cancer Test Shown To Be Powerful Tool for Prognosis Prediction in Postmenopausal Breast Cancer Patients
Date:12/17/2007

Agendia to file for expanded FDA clearance for MammaPrint(R)

AMSTERDAM, Netherlands, Dec. 17 /PRNewswire/ -- Agendia BV, world leader in the rapidly evolving field of molecular diagnostics, announced today that its MammaPrint(R) breast cancer prognosis test was shown to be a valuable tool to assess risk of breast cancer recurrence also in postmenopausal breast cancer patients. Data recently presented at the AACR/NCI/ EORTC conference "Molecular Targets and Cancer Therapeutics: Discovery, Biology, and Clinical Applications" in San Francisco showed that MammaPrint is a valuable tool to assess risk of breast cancer recurrence in older age breast cancer patients as well.

To date, MammaPrint has received two clearances from the Food and Drug Administration (FDA) for its test. The first clearance in February of this year cleared MammaPrint for safety and effectiveness under the In Vitro Diagnostic Multivariate Index Assay (IVDMIA) Guidelines for use in breast cancer prognosis. In June, Agendia received a second clearance for the test in conjunction with RNARetain(R)*, an RNA stabilizing solution allowing shipping of tumor biopsies at ambient temperature, greatly facilitating the logistical process of sample handling. FDA clearance also ensures the validity of the RNA integrity chain from patient to result, which ensures that the whole test procedure is fit for daily clinical settings. With the new data, Agendia will seek additional clearance from the FDA for its MammaPrint breast cancer prognosis test to include patients over age 60.

In the underlying study, breast tumors from 100 patients with lymph node- negative, invasive breast cancer (median age 62 years, but also including elderly patients over age 75) who were diagnosed and treated at the Massachusetts General Hospital in Boston, USA between 1985 and 1997 were subjected to MammaPrint gene expression analysis. MammaPrint, having a digital readout, classified patients as being at eithe
'/>"/>

SOURCE Agendia BV
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Agendias MammaPrint(R), the Only FDA-Cleared Breast Cancer Prognosis Test, is Now Widely Available to U.S. Patients
2. Study Shows MammaPrint(R) Breast Cancer Test Provides Benefits to Patients from Personalized Treatment Regimen
3. Survival differences by race most apparent in advanced stages of breast cancer
4. MRI finds breast cancer before it becomes dangerous
5. Pathway links inflammation, angiogenesis and breast cancer
6. Drop in breast cancer incidence linked to hormone use, not mammograms
7. Breast cancer prevention practices vary across Canada
8. Eating junk food whilst pregnant and breastfeeding may lead to obese offspring
9. Acrylamide Wont Raise Breast Cancer Risk
10. New link between estrogen and breast cancer
11. Hypnosis Eases Pain of Breast Cancer Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2014)... Daily Gossip reveals in its review a ... You program, who shows a unique formula to get inside ... method says that the program goes beyond mere attraction and ... You review indicates that the program was created by dating ... great techniques to make a man feel emotionally addicted. , ...
(Date:8/30/2014)... York (PRWEB) August 30, 2014 ... of Nutrition and Pharameuticals. Nutraceuticals is a source ... healthy ingredients from natural food sources. Nutraceutical ingredients ... benefits to the human body. Nutraceutical health products ... supplements, fortified foods and more. Although nature is ...
(Date:8/30/2014)... 2014 After offering hyperbaric oxygen ... the past several years, Dr. Roy Schmidt and ... announced a scholarship program for veterans who have ... meeting held this summer to discuss veterans’ needs ... have shed light on the large number of ...
(Date:8/30/2014)... August 30, 2014 Hundreds of Byetta ... continue to move forward in U.S. courts, Bernstein Liebhard ... PLC on July 31, 2014, Byetta and Bydureon (an ... product liability claims that allege the drugs caused pancreatitis, ... many of these claims are pending in a multidistrict ...
(Date:8/30/2014)... In today’s world, a good night’s sleep has ... sleep apnea (a medical problem where the airway collapses during ... of the rest they need to face their daily challenges. ... 20 million people in the United States alone have sleep ... and of those treated, many cannot tolerate their prescribed medical ...
Breaking Medicine News(10 mins):Health News:Make Him Desire You Review Reveals Powerful Formula to Make a Man Emotionally Addicted 2Health News:A Granular Analysis of the Nutraceutical Ingredients Market by Transparency Market Research 2Health News:A Granular Analysis of the Nutraceutical Ingredients Market by Transparency Market Research 3Health News:A Granular Analysis of the Nutraceutical Ingredients Market by Transparency Market Research 4Health News:Tennessee Hyperbaric Center Offering HBOT Scholarships to Veterans 2Health News:Byetta Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Settlements in More than 80 Cases 2Health News:Byetta Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Settlements in More than 80 Cases 3Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3
... Star Scientific, Inc. (Nasdaq: STSI ) filed ... Securities and Exchange Commission. The company reported 2008 net ... net sales for 2007. However, volume sales of the ... increased 7.8% in 2008 compared to 2007. The wholesale ...
... From ,Democracy to Despotism, Cardinal Francis George WarnsAlert ... ProtectionsWASHINGTON, March 16 Cardinal Francis George is ... the Obama Administration to retain Health and Human ... workers.This is vital to keep the government from ...
... among Top 10 Companies for Supplier Diversity and for African ... Service Corporation (HCSC) as one of its Top 50 Companies ... In 2009, the company ranks 22, up 12 spots from ... 10 Companies for Supplier Diversity as well as the Top ...
... March 16 Coursework begins today as the American ... states to deliver needed dental care to underserved people ... developed by the ADA over the past several years, ... Dental Health Coordinator (CDHC). CDHCs are drawn from the ...
... Access to Medigap as Additional Coverage Option For ... 16 The National Kidney Foundation of Florida ... Representative Ritch Workman today for co-sponsoring proposed legislation ... for Florida,s end stage renal disease (ESRD) patients ...
... suggests close monitoring offers some men better quality of ... immediate treatment can be safe for men with low-risk ... finds. , The multi-center study of American and Canadian ... or if to treat men with low-risk prostate cancer ...
Cached Medicine News:Health News:Star Scientific Files Annual Financial Report 2Health News:Star Scientific Files Annual Financial Report 3Health News:Star Scientific Files Annual Financial Report 4Health News:Cardinal George Urges Catholics to Tell Administration: Keep Conscience Protections for Health Care Workers 2Health News:Cardinal George Urges Catholics to Tell Administration: Keep Conscience Protections for Health Care Workers 3Health News:Health Care Service Corporation Ranked as One of the Most Diverse Companies in the Country for 5th Consecutive Year 2Health News:Health Care Service Corporation Ranked as One of the Most Diverse Companies in the Country for 5th Consecutive Year 3Health News:Health Care Service Corporation Ranked as One of the Most Diverse Companies in the Country for 5th Consecutive Year 4Health News:ADA Launches Community Dental Health Coordinator Program to Provide Dental Care in Underserved Areas 2Health News:ADA Launches Community Dental Health Coordinator Program to Provide Dental Care in Underserved Areas 3Health News:The National Kidney Foundation of Florida Commends Senator Thad Altman, Representative Ritch Workman for Co-Sponsoring 'Common Sense' Legislation Widely Hailed as 'Good for Patients, Good for Taxpayers, Good for Florida' 2Health News:'Watchful Waiting' Safe With Low-Risk Prostate Cancers 2
(Date:8/29/2014)... , Aug. 29, 2014 Diseases largely ... a generation ago are returning. Measles was declared eliminated ... in 2014 as of August 15—the highest incidence in ... public health department declared whooping cough a problem of ... are getting sick and dying from these preventable diseases—in ...
(Date:8/29/2014)... Aug. 29, 2014  Abaxis, Inc. (NasdaqGS: ... instrumentation and consumables to the medical, research and veterinary ... and Chief Executive Officer, will present at the CL ... on Tuesday, September 9, 2014 at 12:30 p.m. ET. ... Place Hotel in New York City ...
(Date:8/29/2014)... 29, 2014 , Industry ... the inaugural Tweetchat taking place in real-time at ... organised by UBM Live , announces the ... a first of its kind global industry-wide Tweetchat ... supply chain, aimed to stimulate conversations on key ...
Breaking Medicine Technology:Vaccines at the Crossroads: Outbreaks On the Rise Across America 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 3Abaxis, Inc. to Present at CL King's 12th Annual Best Ideas Conference 2014 2CPhI Worldwide to Host #CPhIChat Provoking Debate on the Future of Pharma 2CPhI Worldwide to Host #CPhIChat Provoking Debate on the Future of Pharma 3
... CARLSBAD, Calif., Nov. 22, 2011 Isis Pharmaceuticals, Inc. (NASDAQ: ... up to $14 million from Pfizer Inc. (NYSE: ... from Pfizer,s acquisition of Excaliard.  Upon closing of the acquisition, ... up to an additional $9.6 million could be paid to ...
... NEW YORK, Nov. 22, 2011 ... research report is available in its ... - Global Pipeline Analysis, Competitive Landscape ... http://www.reportlinker.com/p0685952/X-Ray-Systems---Global-Pipeline-Analysis-Competitive-Landscape-and-Market-Forecasts-to-2017.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Imaging ...
Cached Medicine Technology:Isis to Receive Up to $14 Million from Pfizer for Its Acquisition of Excaliard Pharmaceuticals 2Isis to Receive Up to $14 Million from Pfizer for Its Acquisition of Excaliard Pharmaceuticals 3Isis to Receive Up to $14 Million from Pfizer for Its Acquisition of Excaliard Pharmaceuticals 4X-Ray Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 2X-Ray Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 3X-Ray Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 4X-Ray Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 5X-Ray Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 6X-Ray Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 7X-Ray Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 8X-Ray Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 9X-Ray Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 10X-Ray Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 11X-Ray Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 12X-Ray Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 13
Anterior Chamber Needle, 30 g. Angled. 5 mm angled tip. Overall length 20 mm. 5/box....
Anterior Chamber Needle, 23 g. Angled. 7 mm angled tip. Overall length 23 mm. 5/box....
Anterior Chamber Needle, 20 g. Angled. 7 mm angled tip. Overall length 23 mm. 5/box....
Hydrodissection / Aspiration Cannula, 25 g. Angled with right hook. 10 mm angled shaft with 2.5 mm right hook tip. Overall length 20 mm. 5/box....
Medicine Products: